JD Bioscience
June 16, 2025
Company Presentation
Metabolic Diseases
JD Bioscience is an innovative, clinical-stage pharmaceutical company based in South Korea, specializing in the discovery and development of novel therapeutic compounds targeting diseases with high unmet medical needs in the metabolic space, including MASH, IBD, cardiomyopathy, epilepsy, and cancer.
Company HQ City:
Gwangju
Company HQ State:
Gwangju Province
Company HQ Country:
Korea, Republic of
Year Founded:
2017
Lead Product in Development:
GM-60106
CEO
Jin Hee Ahn
Development Phase of Lead Product
Phase II
Number of Unlicensed Products Looking for Licensing
4
When you expect your next catalyst update?
70M USD
What is your next catalyst (value inflection) update?
September 2025
Primary Speaker
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}